Equity Profile

CC

The Chemours Company

MaterialsDiversified Chemicals$2.7B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

The Chemours Company (CC) operates in the materials sector, focusing on diversified chemicals. It plays a crucial role in providing essential materials for various industries, including electronics, automotive, and construction, which are influenced by broader economic trends and consumer demand.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

In Q1 2026, Chemours reported an EPS of $0.05, significantly beating expectations. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Chemours are mixed, with some analysts anticipating continued profitability while others express concerns about revenue stability.

Bull Case

If Chemours can maintain its EPS growth and improve revenue, it could signal strong operational efficiency and market demand, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to show revenue growth or experiences rising costs, it could lead to a decline in investor confidence and a negative stock response.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the revenue growth rate be for this quarter?

Revenue growth is critical for Chemours to demonstrate its ability to expand and meet market demand, influencing investor sentiment.

How will operating margins be affected by raw material costs?

Understanding the impact of raw material costs on operating margins will provide insight into the company's cost management and profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Chemours' ability to leverage cost efficiencies and pass on price increases, which could lead to better-than-expected margins.

Supporting Evidence

The company's recent EPS surprises indicate strong operational performance despite revenue uncertainties.

Options pricing suggests a significant move, indicating that traders expect a more volatile response than historical averages would suggest.

Key Risk

If revenue growth comes in above expectations, it could shift the narrative towards a more favorable outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the balance between revenue growth and cost management, which are critical for Chemours' financial health.

Bull Confirmed If

A revenue growth rate exceeding 5% would confirm the bull case, indicating strong demand and operational efficiency.

Bear Confirmed If

A decline in operating margins below 15% would confirm the bear case, suggesting rising costs are outpacing revenue growth.

Pre-Earnings Positioning

Options Market

Implied Move

±17.46%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.5% while CC has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

76.5%

Calls (40K)P/C Ratio: 1.86Puts (44K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 13 of 30 (43%)

This setup has occurred 30 times across Materials in the last 2 years. 13 of 30 faded and 17 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 4.9%, with a raw directional average of +0.3% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a stock increase of around 3.23%, confirming strong operational performance.

In-Line / Cautious

An in-line report may lead to muted reactions, as investors await further clarity on future guidance and market conditions.

Miss

If the company misses expectations, history suggests a decline of about 1.78%, reflecting investor disappointment in growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on revenue growth rates and any guidance for future quarters.
2Insights into cost management strategies and their impact on operating margins.
3Any updates on new product lines or market expansions.
4Management's outlook on industry trends and demand forecasts.
5Responses to questions regarding competitive pressures and pricing strategies.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

In Q1 2026, Chemours reported an EPS of $0.05, significantly beating expectations. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Chemours are mixed, with some analysts anticipating continued profitability while others express concerns about revenue stability.

Bull Case

If Chemours can maintain its EPS growth and improve revenue, it could signal strong operational efficiency and market demand, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to show revenue growth or experiences rising costs, it could lead to a decline in investor confidence and a negative stock response.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the revenue growth rate be for this quarter?

Revenue growth is critical for Chemours to demonstrate its ability to expand and meet market demand, influencing investor sentiment.

How will operating margins be affected by raw material costs?

Understanding the impact of raw material costs on operating margins will provide insight into the company's cost management and profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Chemours' ability to leverage cost efficiencies and pass on price increases, which could lead to better-than-expected margins.

Supporting Evidence

The company's recent EPS surprises indicate strong operational performance despite revenue uncertainties.

Options pricing suggests a significant move, indicating that traders expect a more volatile response than historical averages would suggest.

Key Risk

If revenue growth comes in above expectations, it could shift the narrative towards a more favorable outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the balance between revenue growth and cost management, which are critical for Chemours' financial health.

Bull Confirmed If

A revenue growth rate exceeding 5% would confirm the bull case, indicating strong demand and operational efficiency.

Bear Confirmed If

A decline in operating margins below 15% would confirm the bear case, suggesting rising costs are outpacing revenue growth.

Pre-Earnings Positioning

Options Market

Implied Move

±17.46%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.5% while CC has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

76.5%

Calls (40K)P/C Ratio: 1.86Puts (44K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 13 of 30 (43%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a stock increase of around 3.23%, confirming strong operational performance.

In-Line / Cautious

An in-line report may lead to muted reactions, as investors await further clarity on future guidance and market conditions.

Miss

If the company misses expectations, history suggests a decline of about 1.78%, reflecting investor disappointment in growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on revenue growth rates and any guidance for future quarters.
2Insights into cost management strategies and their impact on operating margins.
3Any updates on new product lines or market expansions.
4Management's outlook on industry trends and demand forecasts.
5Responses to questions regarding competitive pressures and pricing strategies.